Lv21
166 积分 2023-09-22 加入
Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation
1小时前
已完结
Recent research and development of DYRK1A inhibitors
1小时前
已完结
DYRK1A inhibitors for disease therapy: Current status and perspectives
5天前
已完结
Pharmacophore-oriented 3D molecular generation toward efficient feature-customized drug discovery
6天前
已完结
Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol
7天前
已完结
Conformation states of DYRK1A affected by phosphorylation: Explorations from GaMD simulations and deep learning
11天前
已完结
EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model
8个月前
已完结
Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
10个月前
已完结
Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
10个月前
已完结
Design, Synthesis, and Biological Evaluation of Some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide Hybrids as MTDLs for Alzheimer’s Disease Therapy
11个月前
已完结
皖公网安备34019202002308
